OTC.V is trading 7.3% down at CA$0.45 today on apparent profit taking following a period of strong gains and clinical trial optimism.
- There are no new company-specific press releases or filings as of June 30, 2026, to explain the current price action.
- Recent positive catalysts include clinical updates and a June 2 debt conversion that strengthened the company's balance sheet.
- The decline appears to be driven by normal volatility in a thinly traded small-cap name amid a relatively calm broader market.